Law360, New York (May 01, 2012, 5:11 PM ET) -- Pfizer Inc. said Tuesday that it has settled Brigham Young University's long-running contract and trade secrets lawsuit that claimed one of the school's professors discovered the enzyme behind the development of the drugmaker's anti-inflammatory drugs Bextra and Celebrex.
Both parties declined to release details of the settlement, which had not yet been filed with the District of Utah federal court at press time.
The settlement will resolve close to six years of litigation in which BYU accused Pfizer of breaching two parts of a research agreement...
Pfizer Settles BYU's Long-Running Celebrex Suit
To view the full article, take a free trial now.
